Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014

Pharmaceutical Microbiology

21 Jan 2014 - 22 Jan 2014 - London, UK

Bookmark and Share

SMi’s reputable Pharamceutical Microbiology conference returns for its 3rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.


Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.


Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

Mary-Anne Weatherhead, Qualified Person, Pfizer

Andrew Bartko, Senior Scientist, Battelle

William Wade, Professor of Oral Microbiology, Barts and The London

Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

Amy McDaniel, Associate Director, Production Operations, Pfizer

Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

Stephen Rawling, Microbiology Team Leader, GSK

John Duguid, Principal Process Analytical Scientist, Genzyme

Kim Bowers, Senior Supervisor, Pfizer

Hilary Chan, Quality Scientist IV, Pfizer

Erika Pfeiler, Microbiologist, FDA

Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Be sure to take part in the next instalment by registering online at:

Alternatively contact John Collins on +44(0)20 7827 6734 or email

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos